LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 41

Search options

  1. Article: Bile acid-sensitive human norovirus strains are susceptible to sphingosine-1-phosphate receptor 2 inhibition.

    Tenge, Victoria / Vijayalakshmi Ayyar, B / Ettayebi, Khalil / Crawford, Sue E / Shen, Yi-Ting / Neill, Frederick H / Atmar, Robert L / Estes, Mary K

    bioRxiv : the preprint server for biology

    2024  

    Abstract: Human noroviruses (HuNoVs) are a diverse group of RNA viruses that cause both endemic and pandemic acute viral gastroenteritis. Previously we reported that many strains of HuNoV require bile or bile acid (BA) to infect human jejunal intestinal enteroid ... ...

    Abstract Human noroviruses (HuNoVs) are a diverse group of RNA viruses that cause both endemic and pandemic acute viral gastroenteritis. Previously we reported that many strains of HuNoV require bile or bile acid (BA) to infect human jejunal intestinal enteroid cultures. Of note, BA was not essential for replication of a pandemic-causing GII.4 HuNoV strain. Using the BA-requiring strain GII.3, we found that the hydrophobic BA GCDCA induces multiple cellular responses that promote replication in jejunal enteroids. Further, we found that chemical inhibition of the G-protein coupled receptor, sphingosine-1- phosphate receptor 2 (S1PR2), by JTE-013 reduced both GII.3 infection in a dose- dependent manner and cellular uptake in enteroids. Herein, we sought to determine if S1PR2 is required by other BA-dependent HuNoV strains and BA-independent GII.4, and if S1PR2 is required for BA-dependent HuNoV infection in other segments of the small intestine. We found JTE-013 inhibition of S1PR2 in jejunal HIEs reduces GI.1, GII.3, and GII.17 (BA-dependent) but not the GII.4 Sydney variant (BA-independent) infection, providing additional evidence of strain-specific differences in HuNoV infection. GII.3 infection of duodenal, jejunal and ileal lines derived from the same individual was also reduced with S1PR2 inhibition, indicating a common mechanism of BA-dependent infection among multiple segments of the small intestine. Our results support a model where BA-dependent HuNoV exploit the activation of S1PR2 by BA to infect the entire small intestine.
    Importance: Human noroviruses (HuNoVs) are important viral human pathogens that cause both outbreaks and sporadic gastroenteritis. These viruses are diverse, and many strains are capable of infecting humans. Our previous studies have identified strain-specific requirements for hydrophobic bile acids (BAs) to infect intestinal epithelial cells. Moreover, we identified a BA receptor, sphingosine-1-phosphate receptor 2 (S1PR2), required for infection by a BA-dependent strain. To better understand how various HuNoV strains enter and infect the small intestine and the role of S1PR2 in HuNoV infection, we evaluated infection by additional HuNoV strains using an expanded repertoire of intestinal enteroid cell lines. We found that multiple BA-dependent strains, but not a BA- independent strain, all required S1PR2 for infection. Additionally, BA-dependent infection required S1PR2 in multiple segments of the small intestine. Together these results indicate S1PR2 has value as a potential therapeutic target for BA-dependent HuNoV infection.
    Language English
    Publishing date 2024-01-03
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2024.01.02.573926
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Mapping human norovirus antigens during infection reveals the breadth of the humoral immune response.

    Su, Lynn / Huang, Wanzhi / Neill, Frederick H / Estes, Mary K / Atmar, Robert L / Palzkill, Timothy

    NPJ vaccines

    2023  Volume 8, Issue 1, Page(s) 87

    Abstract: Human noroviruses (HuNoV) are the leading cause of acute gastroenteritis worldwide. The humoral immune response plays an important role in clearing HuNoV infections and elucidating the antigenic landscape of HuNoV during an infection can shed light on ... ...

    Abstract Human noroviruses (HuNoV) are the leading cause of acute gastroenteritis worldwide. The humoral immune response plays an important role in clearing HuNoV infections and elucidating the antigenic landscape of HuNoV during an infection can shed light on antibody targets to inform vaccine design. Here, we utilized Jun-Fos-assisted phage display of a HuNoV genogroup GI.1 genomic library and deep sequencing to simultaneously map the epitopes of serum antibodies of six individuals infected with GI.1 HuNoV. We found both unique and common epitopes that were widely distributed among both nonstructural proteins and the major capsid protein. Recurring epitope profiles suggest immunodominant antibody footprints among these individuals. Analysis of sera collected longitudinally from three individuals showed the presence of existing epitopes in the pre-infection sera, suggesting these individuals had prior HuNoV infections. Nevertheless, newly recognized epitopes surfaced seven days post-infection. These new epitope signals persisted by 180 days post-infection along with the pre-infection epitopes, suggesting a persistent production of antibodies recognizing epitopes from previous and new infections. Lastly, analysis of a GII.4 genotype genomic phage display library with sera of three persons infected with GII.4 virus revealed epitopes that overlapped with those identified in GI.1 affinity selections, suggesting the presence of GI.1/GII.4 cross-reactive antibodies. The results demonstrate that genomic phage display coupled with deep sequencing can characterize HuNoV antigenic landscapes from complex polyclonal human sera to reveal the timing and breadth of the human humoral immune response to infection.
    Language English
    Publishing date 2023-06-06
    Publishing country England
    Document type Journal Article
    ISSN 2059-0105
    ISSN (online) 2059-0105
    DOI 10.1038/s41541-023-00683-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Antiviral Activity of Olanexidine-Containing Hand Rub against Human Noroviruses.

    Ettayebi, Khalil / Salmen, Wilhelm / Imai, Kaoru / Hagi, Akifumi / Neill, Frederick H / Atmar, Robert L / Prasad, B V Venkataram / Estes, Mary K

    mBio

    2022  Volume 13, Issue 2, Page(s) e0284821

    Abstract: Human norovirus (HuNoV) is the leading cause of epidemic and sporadic acute gastroenteritis worldwide. HuNoV transmission occurs predominantly by direct person-to-person contact, and its health burden is associated with poor hand hygiene and a lack of ... ...

    Abstract Human norovirus (HuNoV) is the leading cause of epidemic and sporadic acute gastroenteritis worldwide. HuNoV transmission occurs predominantly by direct person-to-person contact, and its health burden is associated with poor hand hygiene and a lack of effective antiseptics and disinfectants. Specific therapies and methods to prevent and control HuNoV spread previously were difficult to evaluate because of the lack of a cell culture system to propagate infectious virus. This barrier has been overcome with the successful cultivation of HuNoV in nontransformed human intestinal enteroids (HIEs). Here, we report using the HIE cultivation system to evaluate the virucidal efficacy of an olanexidine gluconate-based hand rub (OLG-HR) and 70% ethanol (EtOH
    MeSH term(s) Animals ; Antiviral Agents/metabolism ; Antiviral Agents/pharmacology ; Biguanides ; Blood Group Antigens/metabolism ; Disinfectants/metabolism ; Disinfectants/pharmacology ; Gastroenteritis ; Humans ; Norovirus/physiology ; Swine
    Chemical Substances Antiviral Agents ; Biguanides ; Blood Group Antigens ; Disinfectants ; olanexidine (92C2328G7P)
    Language English
    Publishing date 2022-03-17
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2557172-2
    ISSN 2150-7511 ; 2161-2129
    ISSN (online) 2150-7511
    ISSN 2161-2129
    DOI 10.1128/mbio.02848-21
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: A Standardized Antiviral Pipeline for Human Norovirus in Human Intestinal Enteroids Demonstrates No Antiviral Activity of Nitazoxanide.

    Lewis, Miranda A / Cortés-Penfield, Nicolás W / Ettayebi, Khalil / Patil, Ketki / Kaur, Gurpreet / Neill, Frederick H / Atmar, Robert L / Ramani, Sasirekha / Estes, Mary K

    bioRxiv : the preprint server for biology

    2023  

    Abstract: Human noroviruses (HuNoVs) are the leading cause of acute gastroenteritis. In immunocompetent hosts, symptoms usually resolve within three days; however, in immunocompromised persons, HuNoV infection can become persistent, debilitating, and sometimes ... ...

    Abstract Human noroviruses (HuNoVs) are the leading cause of acute gastroenteritis. In immunocompetent hosts, symptoms usually resolve within three days; however, in immunocompromised persons, HuNoV infection can become persistent, debilitating, and sometimes life-threatening. There are no licensed therapeutics for HuNoV due to a near half-century delay in its cultivation. Treatment for chronic HuNoV infection in immunosuppressed patients anecdotally includes nitazoxanide, a broad-spectrum antimicrobial licensed for treatment of parasite-induced gastroenteritis. Despite its off-label use for chronic HuNoV infection, nitazoxanide has not been clearly demonstrated to be an effective treatment. In this study, we established a standardized pipeline for antiviral testing using multiple human small intestinal enteroid (HIE) lines representing different intestinal segments and evaluated whether nitazoxanide inhibits replication of 5 HuNoV strains
    Language English
    Publishing date 2023-05-23
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2023.05.23.542011
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Standardization of an antiviral pipeline for human norovirus in human intestinal enteroids demonstrates nitazoxanide has no to weak antiviral activity.

    Lewis, Miranda A / Cortés-Penfield, Nicolás W / Ettayebi, Khalil / Patil, Ketki / Kaur, Gurpreet / Neill, Frederick H / Atmar, Robert L / Ramani, Sasirekha / Estes, Mary K

    Antimicrobial agents and chemotherapy

    2023  Volume 67, Issue 10, Page(s) e0063623

    Abstract: Human noroviruses (HuNoVs) are the leading cause of acute gastroenteritis. In immunocompetent hosts, symptoms usually resolve within 3 days; however, in immunocompromised persons, HuNoV infection can become persistent, debilitating, and sometimes life- ... ...

    Abstract Human noroviruses (HuNoVs) are the leading cause of acute gastroenteritis. In immunocompetent hosts, symptoms usually resolve within 3 days; however, in immunocompromised persons, HuNoV infection can become persistent, debilitating, and sometimes life-threatening. There are no licensed therapeutics for HuNoV due to a near half-century delay in its cultivation. Treatment for chronic HuNoV infection in immunosuppressed patients anecdotally includes nitazoxanide, a broad-spectrum antimicrobial licensed for treatment of parasite-induced gastroenteritis. Despite its off-label use for chronic HuNoV infection, nitazoxanide has not been clearly demonstrated to be an effective treatment. In this study, we standardized a pipeline for antiviral testing using multiple human small intestinal enteroid lines representing different intestinal segments and evaluated whether nitazoxanide inhibits replication of five HuNoV strains
    MeSH term(s) Humans ; Norovirus ; Gastroenteritis/drug therapy ; Antiviral Agents/pharmacology ; Antiviral Agents/therapeutic use ; Reference Standards ; Caliciviridae Infections/drug therapy ; Virus Replication
    Chemical Substances nitazoxanide (SOA12P041N) ; Antiviral Agents
    Language English
    Publishing date 2023-10-03
    Publishing country United States
    Document type Journal Article
    ZDB-ID 217602-6
    ISSN 1098-6596 ; 0066-4804
    ISSN (online) 1098-6596
    ISSN 0066-4804
    DOI 10.1128/aac.00636-23
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: CLIC and membrane wound repair pathways enable pandemic norovirus entry and infection.

    Ayyar, B Vijayalakshmi / Ettayebi, Khalil / Salmen, Wilhelm / Karandikar, Umesh C / Neill, Frederick H / Tenge, Victoria R / Crawford, Sue E / Bieberich, Erhard / Prasad, B V Venkataram / Atmar, Robert L / Estes, Mary K

    Nature communications

    2023  Volume 14, Issue 1, Page(s) 1148

    Abstract: Globally, most cases of gastroenteritis are caused by pandemic GII.4 human norovirus (HuNoV) strains with no approved therapies or vaccines available. The cellular pathways that these strains exploit for cell entry and internalization are unknown. Here, ... ...

    Abstract Globally, most cases of gastroenteritis are caused by pandemic GII.4 human norovirus (HuNoV) strains with no approved therapies or vaccines available. The cellular pathways that these strains exploit for cell entry and internalization are unknown. Here, using nontransformed human jejunal enteroids (HIEs) that recapitulate the physiology of the gastrointestinal tract, we show that infectious GII.4 virions and virus-like particles are endocytosed using a unique combination of endosomal acidification-dependent clathrin-independent carriers (CLIC), acid sphingomyelinase (ASM)-mediated lysosomal exocytosis, and membrane wound repair pathways. We found that besides the known interaction of the viral capsid Protruding (P) domain with host glycans, the Shell (S) domain interacts with both galectin-3 (gal-3) and apoptosis-linked gene 2-interacting protein X (ALIX), to orchestrate GII.4 cell entry. Recognition of the viral and cellular determinants regulating HuNoV entry provides insight into the infection process of a non-enveloped virus highlighting unique pathways and targets for developing effective therapeutics.
    MeSH term(s) Humans ; Clathrin ; Norovirus/physiology ; Signal Transduction ; Virus Internalization ; Cell Membrane/virology
    Chemical Substances Clathrin
    Language English
    Publishing date 2023-02-28
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 2553671-0
    ISSN 2041-1723 ; 2041-1723
    ISSN (online) 2041-1723
    ISSN 2041-1723
    DOI 10.1038/s41467-023-36398-z
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: A Bivalent Human Norovirus Vaccine Induces Homotypic and Heterotypic Neutralizing Antibodies.

    Atmar, Robert L / Ettayebi, Khalil / Ramani, Sasirekha / Neill, Frederick H / Lindesmith, Lisa / Baric, Ralph S / Brinkman, Amanda / Braun, Ralph / Sherwood, James / Estes, Mary K

    The Journal of infectious diseases

    2023  Volume 229, Issue 5, Page(s) 1402–1407

    Abstract: A GII.2 outbreak in an efficacy study of a bivalent virus-like particle norovirus vaccine, TAK-214, in healthy US adults provided an opportunity to examine GII.4 homotypic vs GII.2 heterotypic responses to vaccination and infection. Three serologic ... ...

    Abstract A GII.2 outbreak in an efficacy study of a bivalent virus-like particle norovirus vaccine, TAK-214, in healthy US adults provided an opportunity to examine GII.4 homotypic vs GII.2 heterotypic responses to vaccination and infection. Three serologic assays-virus-like particle binding, histoblood group antigen blocking, and neutralizing-were performed for each genotype. Results were highly correlated within a genotype but not between genotypes. Although the vaccine provided protection from GII.2-associated disease, little GII.2-specific neutralization occurred after vaccination. Choice of antibody assay can affect assessments of human norovirus vaccine immunogenicity.
    MeSH term(s) Humans ; Norovirus/immunology ; Norovirus/genetics ; Antibodies, Neutralizing/immunology ; Antibodies, Neutralizing/blood ; Antibodies, Viral/immunology ; Antibodies, Viral/blood ; Caliciviridae Infections/prevention & control ; Caliciviridae Infections/immunology ; Viral Vaccines/immunology ; Adult ; Genotype ; Female ; Young Adult ; Male ; Gastroenteritis/prevention & control ; Gastroenteritis/virology ; Gastroenteritis/immunology ; Vaccines, Virus-Like Particle/immunology ; Middle Aged
    Language English
    Publishing date 2023-10-02
    Publishing country United States
    Document type Journal Article ; Randomized Controlled Trial
    ZDB-ID 3019-3
    ISSN 1537-6613 ; 0022-1899
    ISSN (online) 1537-6613
    ISSN 0022-1899
    DOI 10.1093/infdis/jiad401
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Bile Goes Viral

    Tenge, Victoria R. / Murakami, Kosuke / Salmen, Wilhelm / Lin, Shih-Ching / Crawford, Sue E. / Neill, Frederick H. / Prasad, B. V. Venkataram / Atmar, Robert L. / Estes, Mary K.

    Viruses. 2021 May 27, v. 13, no. 6

    2021  

    Abstract: Laboratory cultivation of viruses is critical for determining requirements for viral replication, developing detection methods, identifying drug targets, and developing antivirals. Several viruses have a history of recalcitrance towards robust ... ...

    Abstract Laboratory cultivation of viruses is critical for determining requirements for viral replication, developing detection methods, identifying drug targets, and developing antivirals. Several viruses have a history of recalcitrance towards robust replication in laboratory cell lines, including human noroviruses and hepatitis B and C viruses. These viruses have tropism for tissue components of the enterohepatic circulation system: the intestine and liver, respectively. The purpose of this review is to discuss how key enterohepatic signaling molecules, bile acids (BAs), and BA receptors are involved in the replication of these viruses and how manipulation of these factors was useful in the development and/or optimization of culture systems for these viruses. BAs have replication-promoting activities through several key mechanisms: (1) affecting cellular uptake, membrane lipid composition, and endocytic acidification; (2) directly interacting with viral capsids to influence binding to cells; and (3) modulating the innate immune response. Additionally, expression of the Na⁺-taurocholate cotransporting polypeptide BA receptor in continuous liver cell lines is critical for hepatitis B virus entry and robust replication in laboratory culture. Viruses are capable of hijacking normal cellular functions, and understanding the role of BAs and BA receptors, components of the enterohepatic system, is valuable for expanding our knowledge on the mechanisms of norovirus and hepatitis B and C virus replication.
    Keywords Hepatitis B virus ; Norovirus ; acidification ; antiviral agents ; bile ; capsid ; hepatitis B ; hepatocytes ; humans ; innate immunity ; intestines ; lipid composition ; liver ; polypeptides ; virus replication
    Language English
    Dates of publication 2021-0527
    Publishing place Multidisciplinary Digital Publishing Institute
    Document type Article
    ZDB-ID 2516098-9
    ISSN 1999-4915
    ISSN 1999-4915
    DOI 10.3390/v13060998
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  9. Article ; Online: A single nanobody neutralizes multiple epochally evolving human noroviruses by modulating capsid plasticity.

    Salmen, Wilhelm / Hu, Liya / Bok, Marina / Chaimongkol, Natthawan / Ettayebi, Khalil / Sosnovtsev, Stanislav V / Soni, Kaundal / Ayyar, B Vijayalakshmi / Shanker, Sreejesh / Neill, Frederick H / Sankaran, Banumathi / Atmar, Robert L / Estes, Mary K / Green, Kim Y / Parreño, Viviana / Prasad, B V Venkataram

    Nature communications

    2023  Volume 14, Issue 1, Page(s) 6516

    Abstract: Acute gastroenteritis caused by human noroviruses (HuNoVs) is a significant global health and economic burden and is without licensed vaccines or antiviral drugs. The GII.4 HuNoV causes most epidemics worldwide. This virus undergoes epochal evolution ... ...

    Abstract Acute gastroenteritis caused by human noroviruses (HuNoVs) is a significant global health and economic burden and is without licensed vaccines or antiviral drugs. The GII.4 HuNoV causes most epidemics worldwide. This virus undergoes epochal evolution with periodic emergence of variants with new antigenic profiles and altered specificity for histo-blood group antigens (HBGA), the determinants of cell attachment and susceptibility, hampering the development of immunotherapeutics. Here, we show that a llama-derived nanobody M4 neutralizes multiple GII.4 variants with high potency in human intestinal enteroids. The crystal structure of M4 complexed with the protruding domain of the GII.4 capsid protein VP1 revealed a conserved epitope, away from the HBGA binding site, fully accessible only when VP1 transitions to a "raised" conformation in the capsid. Together with dynamic light scattering and electron microscopy of the GII.4 VLPs, our studies suggest a mechanism in which M4 accesses the epitope by altering the conformational dynamics of the capsid and triggering its disassembly to neutralize GII.4 infection.
    MeSH term(s) Humans ; Capsid Proteins/chemistry ; Capsid/metabolism ; Norovirus/genetics ; Binding Sites ; Epitopes/metabolism ; Blood Group Antigens/metabolism ; Caliciviridae Infections
    Chemical Substances Capsid Proteins ; Epitopes ; Blood Group Antigens
    Language English
    Publishing date 2023-10-16
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Intramural ; Research Support, U.S. Gov't, Non-P.H.S. ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 2553671-0
    ISSN 2041-1723 ; 2041-1723
    ISSN (online) 2041-1723
    ISSN 2041-1723
    DOI 10.1038/s41467-023-42146-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Comparison of Microneutralization and Histo-Blood Group Antigen-Blocking Assays for Functional Norovirus Antibody Detection.

    Atmar, Robert L / Ettayebi, Khalil / Ayyar, B Vijayalakshmi / Neill, Frederick H / Braun, Ralph P / Ramani, Sasirekha / Estes, Mary K

    The Journal of infectious diseases

    2019  Volume 221, Issue 5, Page(s) 739–743

    Abstract: Background: The development of an in vitro cultivation system for human noroviruses allows the measurement of neutralizing antibody levels.: Methods: Serum neutralizing antibody levels were determined using a GII.4/Sydney/2012-like virus in human ... ...

    Abstract Background: The development of an in vitro cultivation system for human noroviruses allows the measurement of neutralizing antibody levels.
    Methods: Serum neutralizing antibody levels were determined using a GII.4/Sydney/2012-like virus in human intestinal enteroids in samples collected before and 4 weeks after administration of an investigational norovirus vaccine and were compared with those measured in histo-blood group antigen (HBGA)-blocking assays.
    Results: Neutralizing antibody seroresponses were observed in 71% of 24 vaccinated adults, and antibody levels were highly correlated (r = 0.82, P < .001) with those measured by HBGA blocking.
    Conclusions: HBGA-blocking antibodies are a surrogate for neutralization in human noroviruses.
    Clinical trials registration: NCT02475278.
    MeSH term(s) Adolescent ; Adult ; Antibodies, Blocking/immunology ; Antibodies, Neutralizing/immunology ; Antibodies, Viral/analysis ; Antibodies, Viral/immunology ; Blood Group Antigens/immunology ; Caliciviridae Infections/prevention & control ; Caliciviridae Infections/virology ; Female ; Healthy Volunteers ; Humans ; Male ; Middle Aged ; Neutralization Tests ; Norovirus/immunology ; Vaccination ; Viral Vaccines/immunology ; Young Adult
    Chemical Substances Antibodies, Blocking ; Antibodies, Neutralizing ; Antibodies, Viral ; Blood Group Antigens ; Viral Vaccines
    Language English
    Publishing date 2019-10-11
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 3019-3
    ISSN 1537-6613 ; 0022-1899
    ISSN (online) 1537-6613
    ISSN 0022-1899
    DOI 10.1093/infdis/jiz526
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top